Latest News
Zoll to Purchase Automated External Defibrillator Specialist Cardiac Science
Wednesday 12 June 2019

12 June 2019 - US-based medical device maker Zoll Medical Corp., an Asahi Kasei Group company, has signed a definitive agreement to purchase automated external defibrillators, related services, and accessories provider Cardiac Science Corp., the company said.
CSC is a portfolio company of Aurora Resurgence, a Los Angeles-based private equity investment firm.
Zoll's technology enables dispatchers to communicate the locations of registered AEDs to callers reporting potential sudden cardiac arrest incidents.
With the addition of Cardiac Science to the AED Link program more 9-1-1 agencies will be able to help put AEDs in the hands of laypersons and first responders to support life-saving action.
The acquisition is subject to regulatory approval and other customary closing conditions. Additional terms of the agreement are not being disclosed at this time.
Cardiac Science develops, manufactures, and markets automated external defibrillators and related parts, components and accessories.
The company also provides a portfolio of training, maintenance, and support services for AED customers. Cardiac Science has executive offices in Deerfield, Wisconsin. The company has operations in North America, Europe, and Asia and has an installed base of over 500,000 units in nearly 100 countries worldwide.
Zoll Medical Corp., an Asahi Kasei Group company, develops and markets medical devices and software solutions.
With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, therapeutic temperature management, and ventilation, Zoll provides a set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors.
Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents.
With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.
Date Published: 12/06/2019
Target: Cardiac Science Corp
Country: USA
Sector: Healthcare
Type: LBO
Financing: Cash
Status: Agreed
Vendor: Aurora Resurgence
Buyer: Zoll Medical Corp
Terms of the deal were not disclosed